BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17659928)

  • 21. Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
    Boufidou AI; Makedou AD; Adamidis DN; Karvounis HI; Gourassas JT; Kesidis HT; Makedou KG; Papadopoulos CE; Parharidis GE; Louridas GE
    Curr Med Res Opin; 2004; 20(2):175-80. PubMed ID: 15006011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients.
    Tseng CH; Tseng CP; Chong CK; Cheng JC; Tai TY
    Int J Cardiol; 2006 Jul; 111(1):80-5. PubMed ID: 16213608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High levels of C-reactive protein with low total cholesterol concentrations additively predict all-cause mortality in patients with coronary artery disease.
    Jánoskuti L; Förhécz Z; Hosszúfalusi N; Kleiber M; Walentin S; Bálint O; Duba J; Rugonfalvi-Kiss S; Romics L; Karádi I; Füst G; Prohászka Z
    Eur J Clin Invest; 2005 Feb; 35(2):104-11. PubMed ID: 15667581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of homocysteine, C-reactive protein and bilirubin for coronary artery disease.
    Yilmaz N; Ciçek HK; Celik A; Meram I; Kocabas R; Davutoglu V
    East Mediterr Health J; 2007; 13(3):522-35. PubMed ID: 17687824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between serum homocysteine, folate and B12 concentration with coronary artery disease in Thai patients.
    Moleerergpoom W; Sura T; Sritara P
    J Med Assoc Thai; 2004 Jun; 87(6):674-8. PubMed ID: 15279348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of coronary artery disease in nondiabetic hemodialysis patients: a matched case-control study.
    Zumrutdal A; Baltali M; Micozkadioglu H; Torun D; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(1):67-71. PubMed ID: 17365912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.
    Hopkins PN; Wu LL; Hunt SC; Brinton EA
    J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperhomocysteinemia as risk factor in a Mexican population].
    Morales JJ; Sánchez B; Verdejo J; Ponce de León S; Mutchinick OM
    Arch Cardiol Mex; 2003; 73 Suppl 1():S103-5. PubMed ID: 12966656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.
    de Souza AW; Silva NP; de Carvalho JF; D'Almeida V; Noguti MA; Sato EI
    Lupus; 2007; 16(10):782-7. PubMed ID: 17895300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis].
    Sydor A; Drozdz M; Kraśniak A; Miłkowski A; Chmiel G; Małczak J; Zabawa-Hołyś S; Moskal K; Podwysocki A; Szmigielski M; Czarnecka D; Gozdecka H; Kowalczyk-Michałek M; Szczeklik A; Wiecek A; Sułowicz W
    Przegl Lek; 2002; 59(12):962-7. PubMed ID: 12731367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected?
    Uzunlulu M; Oğuz A; Tigen K
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):268-70. PubMed ID: 16330390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
    Bozbaş H; Yildirir A; Pirat B; Eroğlu S; Korkmaz ME; Atar I; Ulus T; Aydinalp A; Ozin B; Müderrisoğlu H
    Anadolu Kardiyol Derg; 2008 Apr; 8(2):111-5. PubMed ID: 18400630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.
    Kumakura H; Fujita K; Kanai H; Araki Y; Hojo Y; Kasama S; Iwasaki T; Ichikawa S; Nakashima K; Minami K
    J Atheroscler Thromb; 2015; 22(4):344-54. PubMed ID: 25296963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population].
    Belkahla R; Omezzine A; Kchok K; Rebhi L; Ben Hadj Mbarek I; Rejeb J; Ben Rejeb N; Slimane N; Nabli N; Ben Abdelaziz A; Boughzala E; Bouslama A
    Ann Cardiol Angeiol (Paris); 2008 Aug; 57(4):219-24. PubMed ID: 18620331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population.
    Hung J; Knuiman MW; Divitini ML; Davis T; Beilby JP
    Am J Cardiol; 2008 Jan; 101(2):193-8. PubMed ID: 18178405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between androgen levels and premature coronary artery disease in men.
    Turhan S; Tulunay C; Güleç S; Ozdöl C; Kilickap M; Altin T; Gerede M; Erol C
    Coron Artery Dis; 2007 May; 18(3):159-62. PubMed ID: 17429287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increase of homocysteine in cardiovascular diseases in Hungary].
    Balogh E; Czuriga I; Bereczky Z; Boda K; Koszegi Z; Kónya C; Császár A; Muszbek L; Edes I; Ferdinandy P
    Orv Hetil; 2006 Sep; 147(35):1685-90. PubMed ID: 17051744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of bone mineral density to predict significant coronary artery disease.
    Marcovitz PA; Tran HH; Franklin BA; O'Neill WW; Yerkey M; Boura J; Kleerekoper M; Dickinson CZ
    Am J Cardiol; 2005 Oct; 96(8):1059-63. PubMed ID: 16214438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.